Search fresh public links, source activity, and post angles for Inter Partes Review.
Fresh curated links around inter partes review are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
With the decline of inter partes review (IPR) proceedings and the significant increase in ex parte reexamination (EPR) proceedings, the U.S. Patent and Trademark Office (USPTO) is...
IPR petition filings have collapsed to historic lows in 2026 — the market's rational response to Director Squires' near-zero institution rate. Continue reading this post on Patentl...
For the first time since the AIA, ex parte reexam requests have eclipsed IPR petitions, driven by the PTO's expanded discretionary-denial regime. Continue reading this post on Pate...
Under a new procedure, announced in an Official Gazette Notice dated April 1, 2026, patent owners may now provide input before the United States Patent and Trademark Office decides...
To challenge recent changes to the inter partes review process issued by the U.S. Patent and Trademark Office, Congress must establish clear statutory guardrails, transparency and...
Addressing the scope of discretionary institution under the America Invents Act (AIA), the United States Patent and Trademark Office (USPTO) denied institution of inter partes revi...
Under a new procedure, announced in an Official Gazette Notice dated April 1, 2026, patent owners may now provide input before the United States Patent and Trademark Office decides...
Addressing the scope of discretionary institution under the America Invents Act (AIA), the United States Patent and Trademark Office (USPTO) denied institution of inter partes revi...
Adversarial proceedings at the US Patent Trial and Appeal Board (PTAB) have undergone significant changes in just one year. The biggest change is not a single doctrinal development...
A recent precedential Federal Circuit decision further clarifies the limited scope of judicial review over PTAB institution-related rulings, holding that refusal by the Patent Tria...
A recent precedential Federal Circuit decision further clarifies the limited scope of judicial review over PTAB institution-related rulings, holding that refusal by the Patent Tria...
U.S. Patent and Trademark Office Director John Squires granted three petitions for inter partes review in his newest bulk order and broke down why he previously rejected CyberSecur...
The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision Wednesday in Federal Express Corporation v. Qualcomm Incorporated, vacating a determination...
Interference proceedings, though increasingly rare, are heavily evidence-based and determine which party is the first inventor when two or more applicants claim the same patentable...
Addressing the scope of appellate review under the America Invents Act, the US Court of Appeals for the Federal Circuit determined that challenges grounded in 35 U.S.C. § 312(a)(2)...
A recent precedential Federal Circuit decision further clarifies the limited scope of judicial review over PTAB institution-related rulings, holding that refusal by the Patent Tria...
The Patent Trial and Appeal Board will no longer conduct an inter partes review into the validity of an Omni MedSci wearable device patent, now that there will be a separate post-g...
The USPTO has issued a precedential decision in an IPR proceeding emphasizing a public-interest-oriented discretionary denial framework under which AIA proceedings must function as...
On April 1, 2026, USPTO Director John Squires issued an Official Gazette Notice establishing a new pre-order procedure effective for reexamination requests filed on or after April...
The U.S. Patent and Trademark Office (USPTO) today held its third PTAB Listening Session, this one focused on Patent Trial and Appeal Board (PTAB) Administration and Reform. Paneli...
The Director of the United States Patent and Trademark Office issued a precedential ruling on May 14, 2026, denying institution of inter partes review (IPR) in Magnolia Medical Tec...
For much of the past decade, post grant patent practice in the United States was dominated by the post-grant proceedings formed as part of the 2013 America Invents Act (AIA), inclu...
With the decline of inter partes review (IPR) proceedings and the significant increase in ex parte reexamination (EPR) proceedings, the U.S. Patent and Trademark Office (USPTO) is...
On May 14, 2026, USPTO (“Office”) Director John Squires issued a precedential decision in Magnolia Medical Technologies, Inc. v. Kurin, Inc. Director Squires denied institution of...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.